Valuation (33%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -78.54 | 12.71 |
| PEG Ratio (TTM) | 0.55 | 2.89 |
| P/S Ratio (TTM) | 1.92 | 4.29 |
| P/B Ratio (TTM) | 1.39 | 2.87 |
| P/FCF Ratio (TTM) | -3.16 | 32.34 |
| Price to 5YR AVG Earnings Ratio | N/A | 36.59 |
| Price to 5YR AVG FCF Ratio | 126.52 | 21.83 |
Profitability (10%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -0.88% | 11.67% |
| ROE (TTM) | -1.88% | 21.71% |
| Net Profit Margin (TTM) | -2.27% | 18.75% |
| ROIC 5YR AVG | 16.81% | 30.41% |
Growth (72%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -55.58% | 93.85% | 110.64% |
| Revenue | 2.43% | 43.11% | 58.64% |
| Net Income | -55.88% | 118.59% | 108.51% |
| Cash Flow | -0.37% | 39.03% | 56.97% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.05 | 1.92 |
| Quick Ratio (TTM) | 0.96 | 1.80 |
| D/E Ratio (TTM) | 0.72 | 0.45 |
| Interest Coverage (TTM) | 5.12 | 23.32 |
| Piotroski F-Score | 6 | 5 |
| Altman Z-Score | 1.77 | 3.11 |
| LTL to 5YR AVG FCF | 56.39 | 16.79 |
| Shares Outstanding Growth 5YR AVG | 15.37% | 21.30% |